相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpression of SmeDEF Efflux Pump Decreases Aminoglycoside Resistance in Stenotrophomonas maltophilia
Yi-Wei Huang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Cyclic Boronates Inhibit All Classes of β-Lactamases
Samuel T. Cahill et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
Steven Marshall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Exploring the Mechanism of β-Lactam Ring Protonation in the Class A β-lactamase Acylation Mechanism Using Neutron and X-ray Crystallography
Venu Gopal Vandavasi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding Proteins
Andrew M. King et al.
ACS CHEMICAL BIOLOGY (2016)
Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates
Karina Calvopina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient
Maria F. Mojica et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Interaction of Avibactam with Class B Metallo-β-Lactamases
Martine I. Abboud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam
David Yuxin Wang et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Investigations on recyclisation and hydrolysis in avibactam mediated serine beta-lactamase inhibition
Hwanho Choi et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
Juergen Brem et al.
NATURE COMMUNICATIONS (2016)
Diffraction-geometry refinement in the DIALS framework
David G. Waterman et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2016)
High-level quinolone resistance is associated with the overexpression of smeVWX in Stenotrophomonas maltophilia clinical isolates
G. Garcia-Leon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
Scott J. Hecker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition
Dustin T. King et al.
ACS INFECTIOUS DISEASES (2015)
Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48
Sushmita D. Lahiri et al.
ACS CHEMICAL BIOLOGY (2015)
Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study
Nikhil P. Krishnan et al.
PLOS ONE (2015)
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Sarah M. Drawz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance
S. D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
Timothy A. Blizzard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe
Ann Versporten et al.
LANCET INFECTIOUS DISEASES (2014)
Global antibiotic consumption 2000 to 2010: an analysis of Cross Mark 742 national pharmaceutical sales data
Thomas P. Van Boeckel et al.
LANCET INFECTIOUS DISEASES (2014)
Coordinate Hyperproduction of SmeZ and SmeJK Efflux Pumps Extends Drug Resistance in Stenotrophomonas maltophilia
Virginia C. Gould et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Involvement of Mutation in ampD I, mrcA, and at Least One Additional Gene in β-Lactamase Hyperproduction in Stenotrophomonas maltophilia
Asmaa Talfan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
Sushmita D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The ABCD's of β-lactamase nomenclature
Karen Bush
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Assay Platform for Clinically Relevant Metallo-β-lactamases
Sander S. van Berkel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
NXL104 Irreversibly Inhibits the β-Lactamase from Mycobacterium tuberculosis
Hua Xu et al.
BIOCHEMISTRY (2012)
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Joanna S. Brooke
CLINICAL MICROBIOLOGY REVIEWS (2012)
The Basis for Carbapenem Hydrolysis by Class A β-Lactamases: A Combined Investigation using Crystallography and Simulations
Fatima Fonseca et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor
David E. Ehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
Ken Coleman
CURRENT OPINION IN MICROBIOLOGY (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non-β-Lactam β-Lactamase Inhibitor
Therese Stachyra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Three Decades of beta-Lactamase Inhibitors
Sarah M. Drawz et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
The antibiotics market
Bashar Hamad
NATURE REVIEWS DRUG DISCOVERY (2010)
Challenging and emerging pathogens in cystic fibrosis
A. M. M. de Vrankrijker et al.
PAEDIATRIC RESPIRATORY REVIEWS (2010)
electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation
Nigel W. Moriarty et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
Structural and Biochemical Characterization of the Interaction between KPC-2 β-Lactamase and β-Lactamase Inhibitor Protein
Melinda S. Hanes et al.
BIOCHEMISTRY (2009)
In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
Therese Stachyra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The MORPHEUS protein crystallization screen
Fabrice Gorrec
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
Stenotrophomonas maltophilia: an emerging opportunist human pathogen
W. John Looney et al.
LANCET INFECTIOUS DISEASES (2009)
The versatility and adaptation of bacteria from the genus Stenotrophomonas
Robert P. Ryan et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Induction of L1 and L2 β-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator
Aki Okazaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants
Lisa C. Crossman et al.
GENOME BIOLOGY (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships
Virginia C. Gould et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
β-Lactam resistance and β-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships
VC Gould et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Absolute quantification of proteins by LCMSE - A virtue of parallel MS acquisition
JC Silva et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Ab initio QM/MM study of class A β-lactamase acylation:: Dual participation of Glu166 and Lys73 in a concerted base promotion of Ser70
SO Meroueh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 β-lactamase -: Insights into the mechanism of inhibition
D Sulton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A review of the antimicrobial activity of clavulanate
J Finlay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Comparison of serum bactericidal activity of ceftazidime, ciprofloxacin and meropenem against Stenotrophomonas maltophilia
SW Lemmen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia
A Alonso et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
